Your session is about to expire
← Back to Search
Contingency Management for Cocaine Use Disorder (RCT (04) Trial)
N/A
Waitlist Available
Led By William W Stoops, Ph.D.
Research Sponsored by William Stoops
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 6 and 12 weeks after study entry, 4, 12 and 24 weeks after study completion.
Awards & highlights
RCT (04) Trial Summary
This trial will show the benefits of reducing cocaine use, rather than quitting entirely. The data will be used to change the accepted treatment goals for cocaine addiction, making it easier to find effective therapies.
Who is the study for?
This trial is for adults over 18 who are seeking treatment for moderate to severe cocaine use disorder, have used cocaine recently (confirmed by a urine test), and can commit to a 12-week intervention with a 24-week follow-up. It's not suitable for those with poor vein access, current serious physical or psychiatric conditions, or a history of severe substance use disorders.Check my eligibility
What is being tested?
The study is testing 'Contingency Management', which rewards patients for reducing their cocaine use. The goal is to understand the positive changes in behavior and health that come from cutting down on cocaine. This could help create better treatment goals and speed up finding new therapies.See study design
What are the potential side effects?
Since this trial focuses on behavioral therapy rather than medication, traditional side effects associated with drugs aren't expected. However, participants may experience stress or anxiety related to changing their drug-use habits.
RCT (04) Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, 6 and 12 weeks after study entry, 4, 12 and 24 weeks after study completion.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 6 and 12 weeks after study entry, 4, 12 and 24 weeks after study completion.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cocaine use
Diastolic blood pressure
Electrocardiogram
+4 moreSecondary outcome measures
Addiction Severity
Adverse events
Cocaine use disorder
+7 moreRCT (04) Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Low Value Alternative Reinforcer GroupExperimental Treatment1 Intervention
This group will receive payment for providing cocaine negative urine samples throughout the trial.
Group II: High Value Alternative Reinforcer GroupExperimental Treatment1 Intervention
This group will receive payment for providing cocaine negative urine samples throughout the trial.
Group III: Control GroupActive Control1 Intervention
This group will receive payment for providing urine samples throughout the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 2
~3430
Find a Location
Who is running the clinical trial?
William StoopsLead Sponsor
8 Previous Clinical Trials
118 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,483 Previous Clinical Trials
2,622,029 Total Patients Enrolled
William W Stoops, Ph.D.Principal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a significant addiction to cocaine.You are currently receiving treatment for cocaine addiction.You have had serious physical or mental health issues (such as addiction or heart problems) that could impact your ability to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Low Value Alternative Reinforcer Group
- Group 3: High Value Alternative Reinforcer Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the primary goals of this medical research project?
"The objective of this 24-week trial is to assess Peripheral Arterial Tonometry (PAT). Secondary objectives involve the evaluation of Cocaine Use Disorder severity, Drug Usage, and Delayed Type Hypersensitivity response to Candida Yeast. The latter will be measured by drawing a line toward the margin of an allergic reaction with a ballpoint pen until resistance due to induration is encountered."
Answered by AI
Are there currently vacancies available for participants in this clinical trial?
"Clinicaltrials.gov indicates that this medical study is actively enrolling patients since it was first listed on September 15th 2017, with the most recent update being June 3rd 2022."
Answered by AI
How many participants are currently partaking in this research project?
"Affirmative. Based on information available from clinicaltrials.gov, this study is actively enrolling participants. It was first advertised in September 15th 2017 and the most recent update was posted June 3rd 2022. The investigators need to recruit 250 subjects at 1 site for their research project."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger